Evidence map›Paper›PMID 24214584›Full record

ReviewJournal of mammary gland biology and neoplasia2013

Multifaceted leptin network: the molecular connection between obesity and breast cancer.

Neeraj K Saxena, Dipali Sharma

Open access · greenAbstract readReview
In one paragraph

Review in Journal of mammary gland biology and neoplasia, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Review
  7. Obesity increases DNA damage in the breast epithelium.Breast cancer research : BCR · 2025
    Article
  8. Exploring the multifaceted role of obesity in breast cancer progression.Frontiers in cell and developmental biology · 2024
    Review
  9. [Effect of Interactions Among Obesity-Related Proteins on Breast Cancer Risk: A Preliminary Study].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2023
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Linkage Between Obesity Leptin and Breast Cancer.Breast cancer : basic and clinical research · 2020
    Review
  20. Epigenetic Regulation of Adipogenesis in Development of Metabolic Syndrome.Frontiers in cell and developmental biology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Neeraj K SaxenaDepartment of Medicine, University of Maryland School of Medicine, 660 W Redwood St., Howard Hall, Rm 301, Baltimore, MD, 21201, USA, nsaxena@medicine.umaryland.edu.
Dipali Sharma
Sidney Kimmel Comprehensive Cancer Center · USUniversity of Maryland, Baltimore · US

Funding

Role of adipocytokines, leptin and adiponectin in breast carcinogenesisR01CA131294 · NCI · JOHNS HOPKINS UNIVERSITY · PI SHARMA, DIPALI · 2009 to 2014
$1.6M
Proliferative Responses to Enteric Bacterial Pathogens in Intestinal TissuesK01DK076742 · NIDDK · EMORY UNIVERSITY · PI MCCONNELL, BETH B · 2007 to 2011
$667k
The role of adiponectin in hepatocelluar carcinomaK01DK077137 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI SAXENA, NEERAJ KUMAR · 2007 to 2010
$502k
Beneficial effects of Honokiol against liver cancerR21CA185943 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI SAXENA, NEERAJ KUMAR · 2015 to 2016
$395k
Adiponectin effects on leptin signaling in hepatocellular carcinomaR03DK089130 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI SAXENA, NEERAJ KUMAR · 2010 to 2011
$149k
NCI NIH HHS R01 CA131294NCI NIH HHS R01CA131294NCI NIH HHS R21 CA185943NIDDK NIH HHS K01 DK076742NIDDK NIH HHS K01DK076742NIDDK NIH HHS K01 DK077137NIDDK NIH HHS R03 DK089130NIDDK NIH HHS R03DK089130
6 · The paper itself

Abstract

High plasma levels of leptin, a major adipocytokine produced by adipocytes, are correlated with increased fat mass in obese state. Leptin is emerging as a key candidate molecule linking obesity with breast cancer. Acting via endocrine, paracrine, and autocrine manner, leptin impacts various stages of breast tumorigenesis from initiation and primary tumor growth to metastatic progression. Leptin also modulates the tumor microenvironment mainly through supporting migration of endothelial cells, neo-angiogenesis and sustaining recruitment of macrophage and monocytes. Various studies have shown that hyperactive leptin-signaling network leads to concurrent activation of multiple oncogenic pathways resulting in enhanced proliferation, decreased apoptosis, acquisition of mesenchymal phenotype, potentiated migration and enhanced invasion potential of tumor cells. Furthermore, the capability of leptin to interact with other molecular effectors of obese state including, estrogen, IGF-1, insulin, VEGF and inflammatory cytokines further increases its impact on breast tumor progression in obese state. This article presents an overview of the studies investigating the involvement of leptin in breast cancer.

Indexed as

AnimalsBreast NeoplasmsFemaleHumansLeptinObesityReceptors, LeptinRisk FactorsSignal TransductionLeptinReceptors, Leptin

Identifiers

PMID24214584
PMCPMC4747028
OpenAlexW2032369680

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.